Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Ik, Hariharan"'
Publikováno v:
Europe PubMed Central
In chronic myeloid leukemia and some cases of acute lymphoblastic leukemia, a 9;22 chromosome translocation has fused most of the c-abl oncogene to a gene designated bcr. To explore in vivo the biological effects of the chimeric gene, we introduced a
Autor:
Aw, Harris, Wy, Langdon, Ws, Alexander, Ik, Hariharan, Rosenbaum H, David Vaux, Webb E, Bernard O, Crawford M, Abud H
Publikováno v:
Europe PubMed Central
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::4504234bedf7197dc137469ce3fa6bc8
http://europepmc.org/abstract/med/3215058
http://europepmc.org/abstract/med/3215058
Publikováno v:
Europe PubMed Central
In chronic myeloid leukemia (CML), a chromosome translocation has fused the bcr gene to the c-abl oncogene, such that a chimeric bcr-abl polypeptide can be made. To explore the biological properties of bcr-abl and compare them with those of the Abels
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::e4620af498c562112a8bd0e338faf69f
http://europepmc.org/abstract/med/3147434
http://europepmc.org/abstract/med/3147434
Publikováno v:
Progress in Modern Biomedicine. Feb2016, Vol. 16 Issue 4, p785-200. 5p.
Publikováno v:
Cell Death & Differentiation. Aug2015, Vol. 22 Issue 8, p1378-1387. 10p. 3 Diagrams, 4 Graphs.
Autor:
Pfleger, Cathie M.1, Jun Wang2, Friedman, Lauren2, Vittorino, Roselle2, Conley, Lindsay M.2, Lap Ho2, Fivecoat, Hayley C.2, Pasinetti, Giulio M.2,3 giulio.pasinetti@mssm.edu
Publikováno v:
International Journal of Alzheimer's Disease. 2010, Vol. 2010, p1-5. 5p. 2 Graphs.
Autor:
Roth, Gerhard
Publikováno v:
Philosophical Transactions of the Royal Society B: Biological Sciences; 12/19/2015, Vol. 370 Issue 1684, p1-9, 9p
Autor:
Robert A. Figlin
Kidney cancer is a heterogenous disease. This book covers: -new surgical approaches which are becoming the standard, i.e., nephon sparing, laporascopic, minimally invasive techniques; -new staging and prognostic capabilities; -evolving therapeutic op